CSE/GEN (CSE/GEN)

Canadian Securities Exchange: CSE/GEN · CAD

CA$0.04

+0.01 (+14.3%)· Recorded snapshot

Market cap	3M
Net income (ttm)	-1.6M
EPS (ttm)	-CA$0.03
Shares out	74.8M
Volume	234,000
Beta	-0.18

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.6M
EPS (ttm): -CA$0.03
Market cap: 3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-53.9

P25 n/aP50 n/aP75 n/a

ROIC-27.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/GEN indicators

Market & fundamental data

Available fields

142

Groups with data

Currency

CAD

Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-24
Enterprise value	CAD 2.5M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-07-31
First seen	2026-07-28
Fiscal year end	April
Founded	2018
Industry	Gold
Is primary listing	Yes
ISIN number	CA37150L1031
Last refreshed	2026-10-29
Market cap	CAD 3M
Next earnings date	2026-12-24
Price	CAD 0.04
Price currency	CAD
Sector	Materials
SIC code	1094
Stock price date	2026-10-28
Symbol	cse/GEN
Website	https://generationuranium.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-73.62%
FCF / EV yield	-61.08%
FCF yield	-50.53%
Industry forward P/E	13.64x
Industry P/E	15.78x
P/B ratio	0.85x
Price / tangible book value	0.85x
Sector forward P/E	15.36x
Sector P/E	22.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-26.6%
ROA (5Y)	-24.04%
ROCE	-37.02%
ROE	-53.91%
ROE (5Y)	-54.85%
ROIC	-27.85%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -195,696
EBIT	CAD -1.3M
EPS	CAD -0.03
FCF per share	CAD -0.02
Financing cash flow	CAD 2M
Free cash flow	CAD -1.5M
Free cash flow minus SBC	CAD -1.8M
Investing cash flow	CAD -195,696
Net borrowing	CAD -10,000
Net cash flow	CAD 497,372
Net income	CAD -1.6M
Operating cash flow minus SBC	CAD -1.6M
Operating income	CAD -1.3M
Stock-based compensation	CAD 256,403

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 0.05
Debt / equity	0
Long-term assets	CAD 3.2M
Long-term liabilities	CAD 0
Net cash (debt)	CAD 517,443
Net cash / market cap	17.28%
Net cash growth	5,037.95%
Net debt / equity	-0.15
Piotroski F-Score	2
Property, plant and equipment	CAD 3.2M
Shareholders' equity	CAD 3.5M
Tangible book value	CAD 3.5M
Tangible book value per share	CAD 0.05
Total assets	CAD 3.7M
Total cash	CAD 517,443
Total debt	CAD 0
Total liabilities	CAD 181,508
WACC	3.24%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 557,699
Current liabilities	CAD 181,508
Current ratio	3.07
Net working capital	CAD -141,252
Quick ratio	2.97
Working capital	CAD 376,191

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-149.16%
Shareholder yield	-149.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.07
1D price change	14.29%
1M price change	-50%
1M total return	-50%
1W price change	-11.11%
1W total return	-11.11%
1Y price change	-50%
1Y return CAGR	-50.02%
1Y total return	-50%
20-day SMA	CAD 0.05
200-day SMA	CAD 0.07
3M price change	-42.86%
3M total return	-42.86%
3Y price change	-11.11%
3Y return CAGR	-3.85%
3Y total return	-11.11%
50-day SMA	CAD 0.06
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.12
52-week high date	2026-01-29
52-week low	CAD 0.03
52-week low date	2026-10-28
6M price change	-42.86%
6M total return	-42.86%
All-time high	CAD 0.44
All-time high date	2024-06-19
All-time low	CAD 0.03
All-time low date	2026-10-28
Average true range (ATR)	CAD 0.01
Average volume	299.6K
Beta (1Y)	-0.05
Beta (2Y)	0.36
Beta (5Y)	-0.18
Change from 52-week high	-65.22%
Change from 52-week low	33.33%
Change from all-time high	-90.8%
Change from all-time low	33.33%
Change from open	33.33%
Day's gap	-14.29%
Dollar volume	CAD 9,360
High price	CAD 0.04
Low price	CAD 0.03
Monthly RSI	41.63
Open price	CAD 0.03
Position in 52-week range	100%
Previous close	CAD 0.04
Price vs 150-day SMA	-41.43%
Price vs 20-day SMA	-16.32%
Price vs 200-day SMA	-43.66%
Price vs 50-day SMA	-34.21%
Relative volume	0.78
RSI	38.88
Sharpe ratio	0.38
Sortino ratio	0.63
Volume	234K
Weekly RSI	37.38
YTD price change	-33.33%
YTD total return	-33.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68.8M
Shares change (QoQ)	38.21%
Shares change (YoY)	149.16%
Shares held by insiders	8.11%
Shares outstanding	74.8M

Deeper analysis on CSE/GEN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/GEN report

Is a complete CSE/GEN research report available?

No complete published report is available for cse/GEN (CSE/GEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/GEN (CSE/GEN)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/GEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/GEN indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/GEN

Frequently asked questions